Wells Fargo & Company Dare Bioscience, Inc. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Dare Bioscience, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 771 shares of DARE stock, worth $262. This represents 0.0% of its overall portfolio holdings.
Number of Shares
771
Previous 758
1.72%
Holding current value
$262
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding DARE
# of Institutions
37Shares Held
6.86MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA3.45MShares$1.17 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA989KShares$336,3640.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny763KShares$259,3860.0% of portfolio
-
Black Rock Inc. New York, NY396KShares$134,6730.0% of portfolio
-
State Street Corp Boston, MA248KShares$84,2210.0% of portfolio
About Dare Bioscience, Inc.
- Ticker DARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,820,896
- Market Cap $28.8M
- Description
- Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...